harvard medical school: "cgrp: a new era for migraine treatment."
.
.
the senate included a provision similar to cusack's bill in its omnibus health care overhaul legislation passed last november, according to sen.
.
china's plans to import indian drugs fail to enthuse indian pharmaceutical firms
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
.